# Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults

> **NCT07161180** · PHASE1 · RECRUITING · sponsor: **Pharmbio Korea Co., Ltd.** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** PBK_M2301 (levodropropizine + Pelargonium sidoides extract)
- **DRUG:** R1_PBK_M2301 (levodropropizine)
- **DRUG:** R2_PBK_M2301 (Pelargonium sidoides extract)

## Key facts

- **NCT ID:** NCT07161180
- **Lead sponsor:** Pharmbio Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-27
- **Primary completion:** 2025-10-30
- **Final completion:** 2025-11-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07161180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07161180, "Evaluation of the Pharmacokinetics of "PBK_M2301" in Healthy Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07161180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*